[HTML][HTML] Psychotropic drugs for the behavioural and psychological symptoms of dementia: no free ride
Psychotropic drugs can play a useful role in the management of behavioural and
psychological symptoms of dementia (eg, situations where the safety of the person with …
psychological symptoms of dementia (eg, situations where the safety of the person with …
Non-pharmacological therapies to manage behavioural and psychological symptoms of dementia: what works and what doesn't
G Livingston, C Cooper - Dementia, 2010 - api.taylorfrancis.com
The neuropsychiatric symptoms of dementia (see Chapter 8, Neuropsychiatric aspects of
dementia and Chapter 9, Measurement of behaviour disturbance, non-cognitive symptoms …
dementia and Chapter 9, Measurement of behaviour disturbance, non-cognitive symptoms …
Managing the behavioral and psychological symptoms of dementia
MF Mendez - Current Treatment Options in Neurology, 2022 - Springer
Abstract Purpose of Review Alzheimer's disease and related dementias are the source of
significant distress, impairment, and caregiver burden in aging populations. A prominent …
significant distress, impairment, and caregiver burden in aging populations. A prominent …
Dementia care: the use and abuse of anti-psychotic drugs
L Nazarko - Nursing And Residential Care, 2009 - magonlinelibrary.com
Dementia care: the use and abuse of anti-psychotic drugs Page 1 MANAGEMENT ISSUES
138 Nursing & Residential Care, March 2009, Vol 11, No 3 Dementia care: the use and abuse …
138 Nursing & Residential Care, March 2009, Vol 11, No 3 Dementia care: the use and abuse …
Psychotropic medication use for behavioral symptoms of dementia
PS Wang, MA Brookhart, S Setoguchi… - Current neurology and …, 2006 - Springer
Behavioral disturbances associated with dementia are common and burdensome. Although
no psychotropic medications are currently approved by the US Food and Drug …
no psychotropic medications are currently approved by the US Food and Drug …
[HTML][HTML] Pharmacological management of behavioral symptoms associated with dementia
S Madhusoodanan, MB Ting - World journal of psychiatry, 2014 - ncbi.nlm.nih.gov
Dementia is a clinical syndrome with features of neurocognitive decline. Subtypes of
dementia include Alzheimer's, frontotemporal, Parkinson's, Lewy body disease, and …
dementia include Alzheimer's, frontotemporal, Parkinson's, Lewy body disease, and …
Drugs used to relieve behavioral symptoms in people with dementia or an unacceptable chemical cosh?
C Ballard, J Cream - International Psychogeriatrics, 2005 - cambridge.org
Introduction Page 1 International Psychogeriatrics (2005), 17:1, 3–29 Co 2005 International
Psychogeriatric Association doi: 10.1017/S104161020500102X Printed in the United Kingdom …
Psychogeriatric Association doi: 10.1017/S104161020500102X Printed in the United Kingdom …
Antipsychotics for behavioral disturbance in dementia? A clinical conundrum
C Schimming, JA Neugroschl - Psychiatric Times, 2012 - go.gale.com
Although cognitive and functional decline are the cardinal features of dementia syndromes,
the associated neuropsychiatric symptoms are some of the most common and troubling …
the associated neuropsychiatric symptoms are some of the most common and troubling …
Antipsychotic use in dementia: is there a problem and are there solutions?
J Kirkham, C Sherman, C Velkers… - The Canadian …, 2017 - journals.sagepub.com
Antipsychotics are necessary for many older adults to treat major mental illnesses or reduce
distressing psychiatric symptoms. Current controversy exists over the role of antipsychotics …
distressing psychiatric symptoms. Current controversy exists over the role of antipsychotics …
Antipsychotics in the management of behavioral and psychological symptoms of dementia: maximizing gain and minimizing harm
RR Tampi, DJ Tampi, K Rogers… - Neurodegenerative …, 2020 - Taylor & Francis
Behavioral and psychological symptoms of dementia (BPSD) include a wide array of
noncognitive symptoms and behaviors that are seen in approximately 90% of individuals …
noncognitive symptoms and behaviors that are seen in approximately 90% of individuals …